Crucell subsidiary ends animal testing
This article was originally published in Scrip
Crucell's Swiss subsidiary Berna Biotech is to close its animal testing facility in Bern, Switzerland, after successfully completing its 3R programme – to Reduce, Refine and Replace all animal testing. Crucell acquired Berna Biotech in 2006 and all of the subsidiary's tests have now been replaced by in vitro assays and any products that were absolutely dependent on animal testing are to be discontinued. The closure of the biotech facility will negatively affect only a few of Crucell's employees as most will be relocated to other departments in its Bern offices, the company said.